Effect of stability of PTEN on hepatocellular carcinoma

  • 0Faculty of Hepato-Pancreato-Biliary Surgery, Chinese PLA General Hospital, No. 28 Fuxing Road, Haidian District, Beijing, China.

|

|

Summary

This summary is machine-generated.

PTEN gene mutations, particularly R130Q, are frequent in hepatocellular carcinoma (HCC), impacting its tumor suppressor function. CRISPR-Cas12a shows promise for detecting PTEN mutations for HCC screening and prognosis.

Area Of Science

  • Oncology
  • Molecular Biology
  • Genetics

Background

  • The phosphatase and tensin homolog (PTEN) gene functions as an antioncogene, crucial for tumor suppression.
  • PTEN mutations can lead to loss of function, contributing to tumorigenesis, particularly in hepatocellular carcinoma (HCC).

Purpose Of The Study

  • To investigate the impact of PTEN mutations on HCC.
  • To elucidate the mechanisms by which PTEN regulates HCC.
  • To explore the diagnostic potential of PTEN mutation detection in HCC.

Main Methods

  • Bioinformatics analysis for PTEN prognosis and mutation frequency in HCC.
  • Functional enrichment analysis (GO, KEGG) of PTEN-related genes using LinkedOmics.
  • CRISPR-Cas12a assay for detecting PTEN R130Q mutation in clinical HCC samples.
  • Dual luciferase reporter gene assays, RT-qPCR, and western blot to identify miR-92a-3p targeting of PTEN.

Main Results

  • Bioinformatics analysis revealed a high mutation frequency at the R130Q/G/L* site of the PTEN gene.
  • The PTEN R130Q mutation was detected in 26 out of 40 clinical HCC samples using CRISPR-Cas12a.
  • miR-92a-3p was identified as a targeting molecule of PTEN.

Conclusions

  • PTEN mutations, especially R130Q, are prevalent in HCC and affect its tumor suppressor role.
  • CRISPR-Cas12a is a potential new clinical tool for PTEN mutation screening and prognosis in HCC.
  • Understanding PTEN's regulatory mechanisms, including microRNA interactions, is vital for HCC research.

Related Concept Videos

Abnormal Proliferation 02:23

4.5K

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...

Interactions Between Signaling Pathways 01:19

6.3K

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

Loss of Tumor Suppressor Gene Functions 01:12

4.8K

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...

PI3K/mTOR/AKT Signaling Pathway 01:22

3.5K

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...

mTOR Signaling and Cancer Progression 03:03

3.8K

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

Cancer-Critical Genes II: Tumor Suppressor Genes 01:05

7.4K

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...